CVS Health’s turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses
MarketWatch
CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect - CNBC
CNBC
Elon Musk says doing something as ordinary as shopping at Target or CVS is no longer possible for him. He explained that the moment he enters a public store, a line for selfies immediately forms, turning a routine errand into a security issue. It is not about being unwilling. He https://t.co/PYNnWBZWOh
@Benzinga
CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings
MarketWatch
Premarket Mover: $CVS +8%
✅ Q1 beats on top & bottom line
🛑 Exiting individual ACA insurance (#Obamacare)
🤝 Teams up with $NVO to boost access to weight-loss drug #Wegovy https://t.co/i9HgDC7DhN
@SeekingAlpha
CVS Health’s Aetna to exit Obamacare business, boost Wegovy access
🇺🇸EARNINGS THIS WEEK:
• APPLE $AAPL
• MICROSOFT $MSFT
• AMAZON $AMZN
• META PLATFORMS $META
• QUALCOMM $QCOM
• EXXONMOBIL $XOM
• CHEVRON $CVX
• ELI LILLY $LLY
• PFIZER $PFE
• CVS HEALTH $CVS
• COCA-COLA $KO
• MCDONALD’S $MCD
• STARBUCKS $SBUX
• DOMINO’S PIZZA $DPZ https://t.co/sSgfg33rYW
@Investingcom
CVS shares are up 45% this year — here's why it may be starting to turn its business around - CNBC
CNBC
CVS wins upgrade to buy as analyst sees more upside potential than its peers
MarketWatch
4 stocks to watch on Wednesday: CVS, CSCO and more
Seeking Alpha
CVS results top estimates even as high medical costs drag down insurance unit - CNBC
CNBC
Stores open Christmas Day 2024: Hours for Walgreens, CVS, Safeway, Acme and more - Axios
Axios
🚨 Insider Alert: CVS Health $CVS Director J. Scott Kirby Buys Shares! 🚨
On Nov. 25, Kirby made a notable move, purchasing 2,933 shares of CVS Health for $167,474. The buy comes at a time when CVS is trading at $58.82, down 2.09% on the day.
🔍 CVS Health Overview:
- Offers… https://t.co/munN2Q1lg4 https://t.co/lFjHMWUzHp
@Benzinga
CVS strikes deal with activist Glenview Capital for four board seats
CNBC
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings https://t.co/NdW2NgC5Yz https://t.co/56fQBql1hq
@Reuters
CVS beats revenue views, but profit missed due to a $1.1 billion reserve charge
MarketWatch
🇺🇸EARNINGS THIS WEEK:
• SUPER MICRO COMPUTER
• ARM HOLDINGS
• QUALCOMM
• ARISTA NETWORKS
• PALANTIR
• DATADOG
• FORTINET
• BLOCK
• DRAFTKINGS
• NOVO NORDISK
• MODERNA
• CVS HEALTH
• FERRARI
• TOYOTA
• LUCID MOTOR
• RIVIAN AUTOMOTIVE
• AIRBNB
• WYNN
• MARRIOTT… https://t.co/cE7U78GI7E https://t.co/qRewq75bos
@Investingcom
Cramer's week ahead: The election, Fed decision and earnings from Super Micro, Arm, Qualcomm and CVS
CNBC
Pennsylvania man charged with insider trading related to CVS takeover https://t.co/NtSTMZofaJ https://t.co/Sv4AbcqiRY
@Reuters
CVS cuts outlook yet again — while swapping out CEO for a company veteran
MarketWatch
CVS ousts CEO Karen Lynch, names Caremark head as new chief - Fortune
Fortune
CVS replaces CEO Karen Lynch with exec David Joyner as profits, share price suffer - CNBC
CNBC
Exclusive: CVS to exit core infusions services business, job cuts possible https://t.co/E82JkeWCS3 https://t.co/AfcNkiNsnR
@Reuters
5 stocks to watch on Friday: RIVN, CVS and more
SeekingAlpha
CVS Health investor Glenview denies it's pushing to break-up company
SeekingAlpha
CVS is reportedly weighing a breakup. Some analysts have mixed feelings.
MarketWatch
CVS is reportedly reviewing its options — including a possible breakup
MarketWatch
Elon Musk’s X Takes On CVS, Unilever in Major Antitrust Lawsuit
CoinOtag
CVS CEO says she's 'taking direct ownership' to fix Aetna insurance business
CNBC
🇺🇸EARNINGS THIS WEEK:
• SUPER MICRO COMPUTER
• PALANTIR
• DATADOG
• FORTINET
• DISNEY
• ELI LILLY
• NOVO NORDISK
• AMGEN
• GILEAD SCIENCES
• CVS HEALTH
• CATERPILLAR
• UBER
• LYFT
• SHOPIFY
• ROBINHOOD
• AIRBNB
• WYNN
• PARAMOUNT GLOBAL
• TYSON FOODS
•… https://t.co/5WNn7mAwCU https://t.co/K90g5rbCL8
@Investingcom
CEO of CVS shares her simple trick to tell whether you're oversharing at work: 'There's a fine line'
CNBC
Jake Paul's personal care brand for Gen Z men was inspired by a rare trip to CVS - Fortune
Fortune
CVS seeks private equity funding for Oak Street Health, Bloomberg News reports https://t.co/DZIiF8RqqA https://t.co/URHDG0qtEo
@Reuters
CVS loses latest bid to escape HIV patients' discrimination lawsuit https://t.co/uBfLw0f8ul https://t.co/jDp1STnCkA
@Reuters
Many CVS drug plans will cover over-the-counter birth control pill at no cost
CNBC
CVS and Walgreens will start dispensing abortion pill mifepristone in select states in coming weeks
CVS closing some pharmacies in Target stores, in the latest industry pullback
MarketWatch
CVS to close 'select' pharmacies in Target stores in the coming months
CNBC
CVS CEO touts expanding primary care health services after major acquisitions
CNBC
Tis The Season! Unveiling Christmas Eve Store Hours For Last-minute Shoppers
Stores like Starbucks and Walmart adjust hours for Christmas Eve.
CVS and Walgreens will maintain normal or slightly altered Christmas Eve schedules. https://t.co/JwxXknVN5q
@Benzinga
CVS Health’s stock jumps as it overhauls prescription-drug pricing
The current price of CVS Health Corp is 91.03 USD — it has increased by 2.64% in the past 24 hours. Watch CVS Health Corp stock price performance more closely on the advanced chart.
What is CVS Health Corp stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange CVS Health Corp stocks are traded under the ticker CVS.
Is CVS stock price going up?
CVS stock has decreased by -0.10% in the past week, has increased by 5.25% in the past month, and has increased by 16.05% in the past year. See more data on CVS chart.
What is the analyst recommendation for CVS?
As of 04 Nov 2026, out of 18 analyst recommendations, the majority rate CVS as a buy.
What is CVS market cap?
As of today, CVS has the market capitalization of 115.43B USD. Explore our list of stocks ranked by market cap to compare CVS with other stocks.
Does CVS release financial reports?
Yes, you can track CVS financials in yearly and quarterly reports on Profit.com.
When is CVS next earnings date?
CVS is going to release the next earnings report on 04 Nov 2026. Keep track of upcoming events with our Earnings Calendar.
What were CVS Earnings for the last quarter?
CVS reported earnings of $2.58 per share for the last quarter, higher then the estimate of $1.87 per share, resulting in a 37.97% surprise. The estimated earnings for the next quarter are $1.62 per share. See more details about CVS earnings on Profit.com.
What was CVS Revenue for the last quarter?
CVS's revenue for the last quarter was 106.1B USD, higher then the estimated 104.69B USD. The estimated revenue for the next quarter is 104.47B USD See more stats in CVS financial reports on Profit.com.
What was CVS Net Income for the last quarter?
CVS net income for the last quarter is 3B USD, while the quarter before that showed 2.94B USD of net income which accounts for 1.77% change. See more stats in CVS financial reports on Profit.com.
Does CVS pay dividends?
Yes, CVS dividends are paid quarterly. The last dividend per share was 2.66. As of today, Dividend Yield (TTM)% is 2.95%.
How many employees does CVS have?
As of 04 Nov 2026, CVS employs approximately 219000 employees. Check out if CVS is on our list of largest employers.
What is CVS EBITDA?
EBITDA, which measures a company's operating performance, reflects its efficiency improvements. CVS EBITDA is 16.68B USD, with a current EBITDA margin of 1.18%. See more stats in CVS financial reports on Profit.com.
How to buy CVS stocks?
Like other stocks, CVS shares are traded on stock exchanges such as NYSE. The easiest way to buy them is through an online stock broker. Simply open an account, follow the broker's procedures, and start trading. Alternatively, you can practice trading Tesla stock on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.
Should I invest in CVS stock?
Investing in stocks requires thorough research, including analyzing the company’s financials, related news, and technical analysis. Currently, Tesla's technical analyst recommendations show a buy rating.